| Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic … M Timmer, K Cesnulevicius, C Winkler, J Kolb, E Lipokatic-Takacs, ... Journal of Neuroscience 27 (3), 459-471, 2007 | 134 | 2007 |
| The atlas of inflammation resolution (AIR) CN Serhan, SK Gupta, M Perretti, C Godson, E Brennan, Y Li, ... Molecular aspects of medicine 74, 100894, 2020 | 118 | 2020 |
| MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation–relevance in a mouse model of Parkinson’s disease T Thomas, M Timmer, K Cesnulevicius, E Hitti, A Kotlyarov, M Gaestel Journal of neurochemistry 105 (5), 2039-2052, 2008 | 102 | 2008 |
| Culturing of glial and neuronal cells on polysialic acid Y Haile, K Haastert, K Cesnulevicius, K Stummeyer, M Timmer, S Berski, ... Biomaterials 28 (6), 1163-1173, 2007 | 87 | 2007 |
| Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate K Cesnulevicius, M Timmer, M Wesemann, T Thomas, T Barkhausen, ... Stem Cells 24 (12), 2776-2791, 2006 | 69 | 2006 |
| Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory … AW Goldman, Y Burmeister, K Cesnulevicius, M Herbert, M Kane, ... Frontiers in Physiology 6, 225, 2015 | 48 | 2015 |
| Characterization and differentiation potential of rat ventral mesencephalic neuronal progenitor cells immortalized with SV40 large T antigen A Nobre, I Kalve, K Cesnulevicius, D Rangancokova, A Ratzka, N Halfer, ... Cell and tissue research 340 (1), 29-43, 2010 | 14 | 2010 |
| Network-and enrichment-based inference of phenotypes and targets from large-scale disease maps M Hoch, S Smita, K Cesnulevicius, D Lescheid, M Schultz, ... NPJ Systems Biology and Applications 8 (1), 13, 2022 | 8 | 2022 |
| AB0080 Differential effects of tr14 versus diclofenac on pro-resolving lipid mediators revealed by rnaseq GS Laurent, I Toma, M Tackett, J Zhou, M Ri, D Shtokalo, Y Vyatkin, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1237-1238, 2018 | 6 | 2018 |
| RNAseq analysis of treatment-dependent signaling changes during inflammation in a mouse cutaneous wound healing model G St. Laurent, I Toma, B Seilheimer, K Cesnulevicius, M Schultz, ... BMC genomics 22, 1-15, 2021 | 4 | 2021 |
| Transfection of primary mesenchephalic progenitors: Efficient nonviral gene delivery in vitro K Cesnulevicius, M Timmer, M Wesemann, C Grothe Cell Transplantation 15 (6), 559-560, 2006 | 4 | 2006 |
| Cell-type-specific gene regulatory networks of pro-inflammatory and pro-resolving lipid mediator biosynthesis in the immune system M Hoch, J Rauthe, K Cesnulevicius, M Schultz, D Lescheid, ... International Journal of Molecular Sciences 24 (5), 4342, 2023 | 3 | 2023 |
| Network analyses reveal new insights into the effect of multicomponent Tr14 compared to single-component diclofenac in an acute inflammation model M Hoch, S Smita, K Cesnulevicius, M Schultz, D Lescheid, ... Journal of Inflammation 20 (1), 12, 2023 | 2 | 2023 |
| THU0021 Differential effects of tr14 versus diclofenac on cox/lox pathways revealed by rnaseq GS Laurent, I Toma, B Seilheimer, M Tackett, J Zhou, M Ri, D Shtokalo, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 238-239, 2018 | 2 | 2018 |
| FGF-2 and FGFR3 are crucial for nigrostriatal development and rescue after 6-OHDA lesion: implications for combined therapies with neural stem cells in Parkinson's disease M Timmer, K Cesnulevicius, C Winkler, K Krampfl, G Nikkhah, C Grothe CELL TRANSPLANTATION 16 (3), 348-348, 2007 | 1 | 2007 |
| Expansion, Differentiation and Transfection of Ventral Mesencephalic Progenitor Cells: Charakterization in Vitro and After Implantation in Animal Model of Parkinson's Disease K Cesnulevicius | 1 | 2006 |
| Expansion, differentiation and transfection of ventral mesencephalic progenitor cells: characterization in vitro and after implantation in animal model of Parkinson's disease K Cesnulevicius Hannover, Tierärztliche Hochsch., Diss., 2006, 2006 | 1 | 2006 |
| System for simulating molecular interactions involved in inflammation SK Gupta, K Cesnulevicius US Patent App. 17/422,726, 2022 | | 2022 |
| Treatment of Dyspepsia, Heartburn, and Related Symptoms with Gastricumeel Compared to Proton Pump Inhibitors: A Prospective Reference-Controlled Observational Study R van Haselen, K Cesnulevicius Complementary Medicine Research 28 (3), 234-243, 2021 | | 2021 |
| AB0063 A SYSTEMS APPROACH TO INVESTIGATE INFLAMMATION RESOLUTION BY MULTICOMPONENT MEDICINAL PRODUCT TR14 P Schopohl, S Smita, F Khan, T Gebhardt, M Hoch, D Brauer, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1496-1496, 2019 | | 2019 |
